By: Kairos Ventures On: May 9, 2017 In: Holoclara, Portfolio News

This Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...

Read more
By: Kairos Ventures On: March 22, 2017 In: Neuro-Bio, Portfolio News

We are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...

Read more
By: Kairos Ventures On: March 7, 2017 In: Delpor, Portfolio News

We are delighted to announce that our portfolio company Delpor has been issued another patent by the United States...

Read more
By: Kairos Ventures On: February 9, 2017 In: Delpor, Portfolio News

Congratulations to our portfolio company Delpor for receiving a new grant award from the National Institute of Mental Health.  The...

Read more

We are very excited to announce that Behavioral Signals has joined the Kairos portfolio, following our investment in their...

Read more
By: Kairos Ventures On: December 1, 2016 In: Portfolio News

Caltech researchers and collaborators, led by Axial Scientific Founder Dr. Sarkis Mazmanian, show for the first time that gut...

Read more

Axial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...

Read more
By: Kairos Ventures On: October 27, 2016 In: Portfolio News, Provivi

Esteemed primatologist, ethologist, and anthropologist Jane Goodall endorses Provivi for its contribution to helping meet the UN’s food production...

Read more

We are thrilled to announce that Applaud Medical, Inc. is the latest company to join our portfolio, following our...

Read more
By: Kairos Ventures On: March 31, 2016 In: Compellon, Portfolio News

We are delighted to announce that Compellon is the latest company to join our portfolio, following our investment in...

Read more